Compugen (CGEN) Return on Capital Employed (2009 - 2026)
Compugen (CGEN) reported Return on Capital Employed of 24.73% for Q1 2026, up 4064.0% on a YoY basis from 0.59% in Q1 2025, and down 17.39% sequentially from 29.94% in Q4 2025.
Compugen (CGEN) Return on Capital Employed (2009 - 2026) Analysis & Trends
Compugen (CGEN) has 18 years of Return on Capital Employed data on file, last reported at 24.73% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed rose 4064.0% year-over-year to 24.73%; the trailing twelve-month figure through Mar 2026 stood at 24.73% (up 4064.0% YoY), and the FY2025 full-year result was 27.67%, up 4286.0% from the prior year.
- Return on Capital Employed eased to 24.73% in Q1 2026, from 29.94% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 29.94% in Q4 2025 to a low of 55.69% in Q3 2023.
- A 5-year average of 9.98% and a median of 15.03% in 2024 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed plunged 5532 bps in 2023 and surged 6756 bps in 2024, its largest moves.
- Tracing CGEN's Return on Capital Employed over 5 years: stood at 3.67% in 2022, then plunged by 619 bps to 19.05% in 2023, then increased by 21 bps to 15.03% in 2024, then soared by 299 bps to 29.94% in 2025, then slipped by 17 bps to 24.73% in 2026.
- Business Quant data shows CGEN's Return on Capital Employed at 24.73% in Q1 2026, 29.94% in Q4 2025, and 39.32% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | Compugen | 221.26 Mn | 129.51 Mn | 352,000.00 | 24.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.73% |
| Dec 31, 2025 | 29.94% |
| Sep 30, 2025 | -39.32% |
| Jun 30, 2025 | -21.91% |
| Mar 31, 2025 | -15.91% |
| Dec 31, 2024 | -15.03% |
| Sep 30, 2024 | 11.87% |
| Jun 30, 2024 | -5.22% |
| Mar 31, 2024 | -15.75% |
| Dec 31, 2023 | -19.05% |
| Sep 30, 2023 | -55.69% |
| Jun 30, 2023 | -51.64% |
| Mar 31, 2023 | 29.23% |
| Dec 31, 2022 | 3.67% |
| Sep 30, 2022 | -2.37% |
| Jun 30, 2022 | 3.68% |
| Mar 31, 2022 | -30.96% |
| Dec 31, 2021 | -31.81% |
| Sep 30, 2021 | -32.94% |
| Jun 30, 2021 | -31.96% |